Occult, overt HBV coinfection predictive of outcomes from HCV-associated HCC

Healio › Hepatology

Occult, overt HBV coinfection predictive of outcomes from HCV-associated HCC

July 16, 2013
Disease-free survival after surgical treatment of hepatitis C-associated hepatocellular carcinoma was significantly influenced by occult or overt hepatitis B coinfection in a recent study.
Researchers evaluated liver tissue from 115 patients with HCV-associated hepatocellular carcinoma (HCC) who underwent total surgical removal of tumors between July 1998 and August 2001 at Chang Gung Memorial Hospital in Linko, Taiwan. All tissue was collected from the noncancerous parts of the removed HCC.
Full Story »

No link between serious infections, nonselective beta blockers among cirrhosis patients
Bajaj JS. Aliment Pharmacol Ther. 2013;doi:10.1111/apt.12382.

July 15, 2013

Patients with cirrhosis treated with nonselective beta blockers are no more likely than nonusers to develop serious infections, according to recent results.

In a retrospective cohort study, researchers evaluated 12,656 patients with compensated and 4,834 patients with decompensated cirrhosis.
Full Story